Management

Chief Executive Officer (CEO)
Since 2026

Gustav Sten

Gustav has considerable experience within the development, production, and quality control of diagnostic products. Gustav joined IDL in 2018. He was previously employed at Thermo Fisher Scientific and Fiomi AB. Gustav has a BSc(Eng) degree.

Holdings in IDL Diagnostics: 84,000 shares and 566,000 warrants.

Chief Financial Officer (CFO)
Since 2022

Ellen Dittberner

Ellen has extensive experience in several different areas such as Group Accounting, Controlling, and Change Management. Ellen has previously worked as Head of Group Accounting at Holmgrens Bil AB. Ellen has an MBA degree.

Holdings in IDL Diagnostics: 566,000 warrants.

    Chief Quality and Regulatory Officer (CQRO)
    Since 2024

    Jocelyn Åkerberg

    Jocelyn has over 24 years of experience in life science, with 5 years in the pharmaceutical industry and 19 years in medical devices. She has served as a Lead Auditor for Quality Management System and Technical/Special Audits at the British Standard Institute, and as a Technical Auditor and Technical Product Reviewer at TÜV- SÜD Product Services GmbH.

     

    Holdings in IDL Diagnostics: null.

      Chief Operations Officer (COO)
      Since 2024

      Maria Sundberg

      Maria has worked in the production and quality control of diagnostic products since 2014. She joined IDL in 2020 and was previously employed at QIAGEN DNA Synthesis AB. Maria holds an MSc in Protein Science.

      Holdings in IDL Diagnostics: null.

      Director of Global Market Development
      Since 2025

      Xia Jiang

      Xia has 17 years of experience in the IVD and medical device industry, with a strong track record in managing distribution channels and expanding markets across Asia-Pacific, Europe, and Africa. She has held several business development roles at Actim (Medix Biochemica Group), Aidian, and Optomed Oy in Finland and China, gaining deep expertise in global commercialization and strategic partnerships. Xia holds a MSc in Financial Management and  Accounting and a BBA in Business Administration.

       

      Holdings in IDL Diagnostics: null.

        Scientific Advisor

        Scientific Advisor

         

        Stig Linder

        Stig Linder has been a scientific advisor at IDL Diagnostics (former AroCell) since 2022. He studied medicine and received his PhD at the Karolinska Institute and did postdoctoral work at Yale University. Stig is now a senior professor at Karolinska Institute and at Linköping University. He has been deputy chairman at the Department of Oncology-Pathology, Karolinska Institute. During his academic career, Stig has supervised or co-supervised approx. 30 PhD students to dissertation.  Stig has previously had an active role in a Swedish start-up diagnostic company (Peviva AB, now VLVBio AB).

        Holdings in IDL Diagnostics: null.

        About us

        We provide knowledge to decision.

        IDL Diagnosticsis a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.

        Read more about us
        Bacteriology

        An effective typhoid test

        Typhoid fever is water and food-borne infectious disease caused by the bacterium, Salmonella enterica. IDL Biotechs product TUBEX® TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.

        Read more about bacteriology
        Contact us

        Email: info@idldiagnostics.com
        Phone: +46 (0)8 799 67 50

        More contact info
        Address

        Karlsbodavägen 39
        168 67 Bromma
        Stockholm
        Sweden

        Follow us
        © 18 June 2026 - All rights reserved IDL Diagnostics AB | Web design by Insign Webbyrå AB